| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/12/2013 | WO2013133442A1 Food or beverage that allows high degree of absorption of water |
| 09/12/2013 | WO2013133408A1 Liquid medicine for internal use |
| 09/12/2013 | WO2013133390A1 Anti-nephropathic drug |
| 09/12/2013 | WO2013133325A1 Tricyclic compound |
| 09/12/2013 | WO2013133217A1 Glucose uptake promoter |
| 09/12/2013 | WO2013133032A1 Dipeptidyl peptidase-iv inhibitor |
| 09/12/2013 | WO2013133031A1 Dipeptidyl peptidase-iv inhibitor |
| 09/12/2013 | WO2013132670A1 Semi-solidified nutritive agent |
| 09/12/2013 | WO2013132668A1 Composition comprising imidazole peptide and quercetin glycoside |
| 09/12/2013 | WO2013132092A1 Use of monounsaturated fatty acid compounds for controlling the body weight of a dog or a cat |
| 09/12/2013 | WO2013131967A1 Pharmaceutical compositions comprising metformin and a dpp -4 inhibitor or a sglt-2 inhibitor |
| 09/12/2013 | WO2013131935A1 Pyridinone and pyridazinone derivatives as mch - receptor modulators |
| 09/12/2013 | WO2013131270A1 Scutellarin hydrate and preparation method and use thereof |
| 09/12/2013 | WO2013131157A1 Combination of a monosubstituted sulfamate derivative of the natural monosaccharide d-fructose (topiramate) with an anti-depressant from the phenyl ketone class (bupropion) for treating obesity and plurimetabolic syndromes |
| 09/12/2013 | WO2013131125A1 Dietary supplement |
| 09/12/2013 | WO2013131124A1 Dietary supplement for pet mammals |
| 09/12/2013 | WO2013064913A3 Method for treating type i and type ii diabetes |
| 09/12/2013 | WO2012098537A8 Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells |
| 09/12/2013 | US20130237961 Intradermal delivery of substances |
| 09/12/2013 | US20130237960 Intradermal delivery of substances |
| 09/12/2013 | US20130237605 Compositions, methods, and kits for regulating energy metabolism |
| 09/12/2013 | CA2809012A1 Use and device for treating blood cholesterol disorders |
| 09/11/2013 | EP2635580A2 Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate |
| 09/11/2013 | EP2635563A1 Crystalline forms of hydrochloride salt of (4a-r,9a-s) -1- (1h - benzoimidazole- 5 -carbonyl) -2, 3, 4, 4a, 9, 9a - hexahydro -1h- indeno [2, 1 -b]pyridine- 6 -carbonitrile and their use as hsd 1 inhibitors |
| 09/11/2013 | EP2635562A1 Pyrrolidine derivatives used as cathepsin inhibitors |
| 09/11/2013 | EP2635270A1 Methods of treatment using lipid compounds |
| 09/11/2013 | EP2635268A1 Pharmaceutical combinations for the treatment of metabolic disorders |
| 09/11/2013 | EP2155221B1 A method for modifying polyphenol containing plant materials and medical uses of modified polyphenol plant containing materials |
| 09/11/2013 | CN1906296B Methods for the production of apolipoproteins in transgenic plants |
| 09/11/2013 | CN103298817A Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 09/11/2013 | CN103298801A 4- (5-cyano-pyrazol-1-yl) -piperidine derivatives as GPR 119 modulators |
| 09/11/2013 | CN103298488A Peptide or peptide complex binding to 2 integrin and methods and uses involving the same |
| 09/11/2013 | CN103298478A Suppressor for increase in blood gip level, suppressor for increase in blood insulin level, postprandial blood triglyceride level reducing agent, and suppressor for increase in blood glucose level |
| 09/11/2013 | CN103298477A Composition comprising cudrania tricuspidata and coix lachryma-jobi having an obesity-suppressing activity and blood-sugar lowering effect, and a use therefor |
| 09/11/2013 | CN103298469A Use of the fetal reprogramming of a PPAR delta agonist |
| 09/11/2013 | CN103289980A Protease screening methods and proteases indentified thererby |
| 09/11/2013 | CN103288978A Fucosan sulphate and preparation method and application thereof in preparation of antidiabetic alpha-glycosidase inhibitor |
| 09/11/2013 | CN103288957A Antibody drug derivative inhibiting tumor growth, its preparation method and use |
| 09/11/2013 | CN103288913A Novel compound, pharmaceutical compositions thereof as well as preparation methods thereof and use of novel compound and pharmaceutical compositions |
| 09/11/2013 | CN103288889A Anthraquinone derivatives, their pharmaceutical compositions and application in medicine preparation |
| 09/11/2013 | CN103288826A Alkaloid component in Nigella glandulifera Freyn seeds as well as preparation method and use thereof |
| 09/11/2013 | CN103288821A Palmatine derivative and preparation method and application thereof |
| 09/11/2013 | CN103288815A Beta-lactamyl vasopression V1a antagonists |
| 09/11/2013 | CN103288738A Nitrogen-containing heterocyclic derivative having 11 beta-hydroxysteroid dehydrogenase type I inhibitory activity |
| 09/11/2013 | CN103288728A Naphthoyl amine derivative, and preparation method and application thereof |
| 09/11/2013 | CN103288721A (4-(4-[6-(trifluoromethyl-pyridin-3-ylamino)-n-containing-heteroaryl]-phenyl)-cyclohexyl)-acetic acid derivatives and pharmaceutical uses thereof |
| 09/11/2013 | CN103285406A MicroRNA-203, and application of analogue thereof in preparation of medicament for preventing and treating obesity, dyslipidemia and complication of obesity and dyslipidemia |
| 09/11/2013 | CN103285398A Compound preparation containing DPP-IV (dipeptidyl peptidase-IV) inhibitor and type-II diabetes medicine and preparation method thereof |
| 09/11/2013 | CN103285394A Use of nitrated lipids for treatment of lipid disorders and obesity, and lipid- and obesity-related conditions |
| 09/11/2013 | CN103285383A Pharmaceutical composition comprising bromelain and bromelain enteric-coated tablet |
| 09/11/2013 | CN103285379A Use of GLP-1 (Glucagon-Like Peptide-1) for preparing medicines for preventing and treating macrovascular complications of type 2 diabetes |
| 09/11/2013 | CN103285378A Use of GLP-1 (Glucagon-Like Peptide-1) for preparing medicines for preventing and treating type 2 diabetic cardiomyopathy |
| 09/11/2013 | CN103285375A Phycocyanin microsphere preparation and preparation method thereof |
| 09/11/2013 | CN103285358A Traditional Chinese medicine preparation capable of treating type-II diabetes mellitus |
| 09/11/2013 | CN103285295A Traditional Chinese medicine preparation |
| 09/11/2013 | CN103285277A Umbilical sticking agent for reducing weight and preparation method thereof |
| 09/11/2013 | CN103285259A Traditional Chinese medicine composition for treating hyperlipidemia |
| 09/11/2013 | CN103285243A Granules for treating hyperglycemia |
| 09/11/2013 | CN103285231A Medicine composition for diabetes adjunctive therapy and preparation method thereof |
| 09/11/2013 | CN103285227A Hypoglycemic Chinese medicine composition, hypoglycemic tea and preparation method of hypoglycemic tea |
| 09/11/2013 | CN103285220A Traditional Chinese medicine for treating hypertension |
| 09/11/2013 | CN103285211A Traditional Chinese medicine particles for treating pathological obesity and preparation method |
| 09/11/2013 | CN103285163A Formula of traditional Chinese medicine for treating diabetes with other complications |
| 09/11/2013 | CN103285159A Body-building nutritional and health-care capsule |
| 09/11/2013 | CN103285113A Pharmaceutical composition for preventing and/or treating diabetes mellitus |
| 09/11/2013 | CN103285110A Traditional Chinese medicine for treating hyperlipidemia and preparation method thereof |
| 09/11/2013 | CN103285084A Production method for fructus schizandrae extract dripping pills |
| 09/11/2013 | CN103285072A Hyperoside-containing extract and medical application thereof |
| 09/11/2013 | CN103285070A Preparation method and application of chickpea sprout extract dispersible tablet |
| 09/11/2013 | CN103285056A Traditional Chinese medicine preparation for preventing and curing cardiovascular diseases and preparation method thereof |
| 09/11/2013 | CN103285027A Application of chroogomphus rutilus mycelium polysaccharide in preparation of blood sugar reducing medicines |
| 09/11/2013 | CN103285008A Applications of Myriberine A in the preparation of antidiabetic drugs |
| 09/11/2013 | CN103285000A Use of alkaloid with framework types I and II in Nigella glandulifera Freyn seeds |
| 09/11/2013 | CN103284999A Application of effective part of ramulus mori alkaloid in preparation of hypoglycemic drug |
| 09/11/2013 | CN103284986A 2-(4-methoxyphenoxy) propionic acid and application of metal salt thereof in preparation of medicament for lowering blood fat |
| 09/11/2013 | CN103284984A Process for the production of 2-[4-(3- and 2-flu0r0benzyl0xy)benzylamin0]propanamides |
| 09/11/2013 | CN103284975A Metformin hydrochloride enteric capsule and preparation method thereof |
| 09/11/2013 | CN103284964A Children zinc gluconate-milk composition freeze-dried oral disintegrating tablet and preparation method thereof |
| 09/11/2013 | CN103284963A Children calcium gluconate-milk composition freeze-dried oral disintegrating tablet and preparation method thereof |
| 09/11/2013 | CN103284952A Medical composition containing fenofibrate |
| 09/11/2013 | CN103284913A Fat-dissolving essential oil |
| 09/11/2013 | CN103284158A Goose oil diacylglycerol microcapsules |
| 09/11/2013 | CN103284152A Dietary fiber extracted from Chinese yew, extraction method and use |
| 09/11/2013 | CN103284148A Processing method of persimmon leaf concentrated powder rich in natural vitamin C |
| 09/11/2013 | CN103284146A L-carnitine tea polyphenol tablet and preparation method thereof |
| 09/11/2013 | CN103284043A Health care product with efficacy of losing weight |
| 09/11/2013 | CN102836353B Chinese medicine for treating diabetes |
| 09/11/2013 | CN102823859B Composition comprising medlar, chrysanthemum or honeysuckle and calcium gluconate |
| 09/11/2013 | CN102823792B Soft propolis astragalus mongholicus capsule and preparation method thereof |
| 09/11/2013 | CN102805826B Drug for reducing weight and beautifying facial appearance and preparation method thereof |
| 09/11/2013 | CN102793891B Traditional Chinese medicine composition having functions of reducing blood fat and resisting hyperuricemia |
| 09/11/2013 | CN102743646B Medicinal composition for inspecting and preventing diabetes |
| 09/11/2013 | CN102675199B Protein complex acid phosphatase inhibitor as well as preparation method and purpose of protein complex acid phosphatase inhibitor |
| 09/11/2013 | CN102641430B Traditional Chinese medicine decoction for treating diabetic nephropathy (DN) |
| 09/11/2013 | CN102604855B Bifidobacterium longum SQS7-31, as well as preparation method and application thereof |
| 09/11/2013 | CN102580048B Chinese medicine for losing weight and preparation method thereof |
| 09/11/2013 | CN102579882B Dropping pills for preventing and curing hypertension and hyperlipidemia and preparation method |
| 09/11/2013 | CN102579589B Application of Chinese medicinal composition in preparing hypoglycemic drugs or health-promoting products |
| 09/11/2013 | CN102526639B Chinese medicinal composition for treating hyperlipidemia and preparation method thereof |
| 09/11/2013 | CN102526436B Slimming capsule and preparation method and application thereof |